DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Giantonio BJ, Catalano PJ, Meropol NJ.
High-dose bevacizumab improves survival when combined with FOLFOX4 in previously treated advanced colorectal cancer: Results from the Eastern Cooperative Oncology Group (ECOG) study E3200.
ASCO 2005; Abstract: 2-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.